q2QHR reported ebita and rev for q2. Total revenue declined from q1 by 200k.
EMR was down 100k, EMS is down 140k RCM up 40. (RCM increased it's bleed to a quarter million for the q The Finance person in an interview expected the division would be 10% of sales by year end. Either they need to grow by 30% in the next few months, or the total rev for the co. needs to decline a bunch.) Not a blowout growth quarter.
There are no net numbers, but after amortization there will not be much net earnings I assume.
Q3, the summer, is slower, so I expect further sales reductions, Given that most of the Healthscreen conversion sales numbers have been billed, the normalized EMR revenue should be seen in Q3.
I might comment after sedar updates.